HomeDMPHF • OTCMKTS
add
Dermapharm Holding SE
Previous close
$42.68
Year range
$42.68 - $42.68
Market cap
2.06B EUR
P/E ratio
-
Dividend yield
-
Primary exchange
ETR
Market news
Financials
Income Statement
Revenue
Net income
| (EUR) | Sep 2024info | Y/Y change |
|---|---|---|
Revenue | 314.56M | 9.48% |
Operating expense | 135.61M | 3.23% |
Net income | 32.39M | 30.38% |
Net profit margin | 10.30 | 19.08% |
Earnings per share | — | — |
EBITDA | 81.11M | 26.78% |
Effective tax rate | 29.98% | — |
Balance Sheet
Total assets
Total liabilities
| (EUR) | Sep 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 118.57M | 0.97% |
Total assets | 2.12B | -1.68% |
Total liabilities | 1.53B | -4.96% |
Total equity | 589.04M | — |
Shares outstanding | 53.99M | — |
Price to book | 3.95 | — |
Return on assets | 7.02% | — |
Return on capital | 9.35% | — |
Cash Flow
Net change in cash
| (EUR) | Sep 2024info | Y/Y change |
|---|---|---|
Net income | 32.39M | 30.38% |
Cash from operations | 73.67M | 14.71% |
Cash from investing | -6.54M | -159.56% |
Cash from financing | -114.10M | -105.57% |
Net change in cash | -47.43M | -813.19% |
Free cash flow | -4.83M | -116.22% |
About
Dermapharm Holding SE or Dermapharm AG, based in Grünwald, is a publicly listed German pharmaceutical company specializing in the manufacture and distribution of dermatological and allergological preparations. Wikipedia
Founded
1991
Website
Employees
3,603
